U.S. JPML Orders Consolidation Of Xarelto Lawsuit Filings

June 27, 2016 – – TheProductLawyers.com reports on the consolidation of more than 2,800 cases against Xarelto and the drug’s manufacturers, Bayer AG, and Janssen Pharmaceuticals. In October of 2015, plaintiffs petitioned the U.S. Judicial Panel on Multidistrict Litigation (JPML) and requested that all lawsuits with similar claims be combined. They also requested that the suits be heard in the Southern District of Illinois. However, defense lawyers protested this move, citing New Jersey as a more appropriate venue for the trials, since many of their corporate locations are based there.

On December 4th, members of the JPML issued a statement announcing their decision. After conducting hearings in which all evidence was evaluated, they announced, “In our judgment, the considerable growth in the litigation over the past few months demonstrates that informal coordination is not practical.” They also announced the appointment of an experienced judge, stating, “Judge Eldon E. Fallon, who presides over three potential tag-along actions, is an experienced transferee judge with the willingness and ability to manage this litigation efficiently. He is well-versed in multidistrict litigation and we are confident he will steer this matter on a prudent course.”

The JPML issued their decision and the consolidation occurred on December 12th of last year. The purpose of the mass litigation is two-fold. First, JPML dictated that all federally-filed cases against Xarelto and its manufacturers be moved to the neutral location selected for trial in order to conserve time and other resources. Second, consolidation prevents duplicitous discovery on the part of the defense and excessively different rulings from innumerable courts. The MDL will be tried in the Eastern District of Louisiana.

While the plaintiffs involved in the MDL cases await the court dates, another consolidation of suits was consolidated in Pennsylvania. Comprising 550 individual suits against Xarelto, a mass tort program has been formed and is slated to appear before the Philadelphia Court of Common Pleas. The pressing need for resolution of stated grievances against Xarelto’s manufacturers leads many plaintiffs to believe that the number of individual suits will continue to grow in the coming months.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60011027